Strategic, feasibility, economic, and cultural aspects of phase 0 approaches

Clinical and translational science, 2022-06, Vol.15 (6), p.1355-1379 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. ;COPYRIGHT 2022 John Wiley & Sons, Inc. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1752-8054 ;EISSN: 1752-8062 ;DOI: 10.1111/cts.13269

Full text available